US EditionAfter NIH staffing cuts, cancer patient in clinical trial worries she may lose crucial time
- Natalie Phelps, a 43-year-old mother of two with stage IV colorectal cancer, was accepted last month into an NIH clinical trial for immunotherapy treatment.
- Her treatment delay stems from recent staff cuts and restructuring at NIH by the Trump administration, which reduced about 1,200 jobs to save $1.8 billion annually.
- The staff reductions caused the cell engineering process time for her T-cell therapy to expand from four to eight weeks, as fewer researchers remain on the trial.
- Phelps emphasized that some scientists on her trial were among the cuts and warned, "Trial delay could cost them their life," highlighting the urgency amid cancer spreading.
- This delay risks worsening her condition and reflects broader concerns about cutting cancer research funding by 31%, despite rising colorectal cancer rates in younger adults.
Insights by Ground AI
Does this summary seem wrong?
28 Articles
28 Articles
All
Left
4
Center
9
Right
3
Prenatal Testing Incidentally Finds Cancer in Mothers, Becomes Focus of New National Institutes of Health Long-term Study
Discovery could lead to new clinical laboratory testing for cancer screening in new mothers Any clinical laboratory test that returns unexpected results is worth looking into more deeply. Such was the case with a recent study conducted by the National Institutes of Health (NIH), which investigated cases of pregnant women who received “unusual” results to […] The post Prenatal Testing Incidentally Finds Cancer in Mothers, Becomes Focus of New Nat…
Coverage Details
Total News Sources28
Leaning Left4Leaning Right3Center9Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 25%
C 56%
R 19%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
